Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.
If you have purchased a print title that contains an access token, please see the token for information about how to register your code.
- Chapter 1 IntroductionMichael A. Stoto
- Chapter 2 Did Advances in Global Surveillance and Notification Systems Make a Difference in the 2009 H1N1 Pandemic?Michael A. Stoto and Ying Zhang
- Chapter 3 The Effectiveness of U.S. Public Health Surveillance Systems for Situational Awareness during the 2009 H1N1 PandemicMichael A. Stoto
- Chapter 4 Variability in School Closure Decisions in Response to 2009 H1N1Tamar Klaiman, John D. Kraemer, and Michael A. Stoto
- Chapter 5 Wearing Many Hats: Lessons about Emergency Preparedness and Routine Public Health from the H1N1 ResponseMatthew W. Lewis, Edward W. Chan, Christopher Nelson, Andrew S. Hackbarth, Christine A. Vaughan, Alonzo Plough, and Brit K. Oiulfstad
- Chapter 6 Variation in the Local Management of Publicly Purchased Antiviral Drugs during the 2009 H1N1 Influenza PandemicJennifer C. Hunter, Daniela C. Rodríguez, and Tomás J. Aragón
- Chapter 7 The H1N1 Response from the Perspective of State and Territorial Immunization Program Managers: Managing the Vaccination CampaignAllison T. Chamberlain, Melissa A. Higdon, Katherine Seib, and Ellen A. S. Whitney
- Chapter 8 Implementing a National Vaccination Campaign at the State and Local Levels: Massachusetts Case StudyMichael A. Stoto and Melissa A. Higdon
- Chapter 9 The Italian Response to the 2009 H1N1 PandemicElena Savoia, Pierluigi Macini, and Maria Pia Fantini
- Chapter 10 Local Health Department Vaccination Success during 2009 H1N1Tamar Klaiman, Katherine O’Connell, and Michael A. Stoto
- Chapter 11 Public Communication during the 2009 H1N1 PandemicElena Savoia, Leesa Lin, and Kasisomayajula Viswanath
- Chapter 12 Obstacles to pH1N1 Vaccine Availability: The Complex Contracting Relationship between Vaccine Manufacturers, the World Health Organization, Donor and Beneficiary GovernmentsSam F. Halabi
- Chapter 13 Implications for Policy and PracticeMichael A. Stoto